Cargando…
Improved bioavailability of cromolyn sodium using inhaled PA101 delivered via eFlow® nebulizer
In 1960s, cromolyn sodium (CS) has been introduced as the first non-steroidal anti-inflammatory drug for the treatment of allergic and mast-cell driven diseases. Its applicability has been limited due to a poor bioavailability. Here we present pharmacokinetic data of a novel high concentration formu...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480408/ https://www.ncbi.nlm.nih.gov/pubmed/32944204 http://dx.doi.org/10.1080/20018525.2020.1809083 |